Cargando…
Role of Intracellular Amyloid β as Pathway Modulator, Biomarker, and Therapy Target
The β- and γ-secretase-driven cleavage of the amyloid precursor protein (APP) gives rise to the amyloid β peptide, which is believed to be the main driver of neurodegeneration in Alzheimer’s disease (AD). As it is prominently detectable in extracellular plaques in post-mortem AD brain samples, resea...
Autores principales: | Gallego Villarejo, Lucia, Bachmann, Lisa, Marks, David, Brachthäuser, Maite, Geidies, Alexander, Müller, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103247/ https://www.ncbi.nlm.nih.gov/pubmed/35563046 http://dx.doi.org/10.3390/ijms23094656 |
Ejemplares similares
-
Amyloid precursor protein elevates fusion of promyelocytic leukemia nuclear bodies in human hippocampal areas with high plaque load
por: Marks, David, et al.
Publicado: (2021) -
Pharmacological targeting of the β-amyloid precursor protein intracellular domain
por: Branca, Caterina, et al.
Publicado: (2014) -
APP intracellular domain/WAVE1 pathway reduces amyloid β production
por: Ceglia, Ilaria, et al.
Publicado: (2015) -
Intracellular Cleavage of Amyloid β by a Viral Protease NIa Prevents Amyloid β-Mediated Cytotoxicity
por: Shin, Baehyun, et al.
Publicado: (2014) -
Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity
por: Gallego-Villarejo, Lucía, et al.
Publicado: (2022)